EDDIE VEDDER, PETE TOWNSHEND To Celebrate THE WHO At Benefit For TEEN CANCER AMERICA
April 14, 2015Pete Townshend, guitarist and principal songwriter of THE WHO and co-founder of Teen Cancer America, will come together with Evanston, Illinois native and PEARL JAM frontman Eddie Vedder on May 14 for one memorable night of music and celebration of THE WHO as part of ongoing efforts to raise money for teenagers with cancer in America.
Money raised from this show will be used to support programs for teenagers and young adults with cancer at the University of Chicago Medicine along with other local children's charities.
For over 15 years, THE WHO bandmembers have been patrons of the successful U.K. charity Teenage Cancer Trust. Through their efforts, the rock group has raised millions of dollars through performances and special events. In 2012, Roger Daltrey and Townshend established Teen Cancer America to replicate their work in this country. Townshend has chosen Chicago as the city to host this very special fundraising performance. Vedder, who has supported teen cancer fundraising efforts by accompanying THE WHO in various performances, will step up once again to help make this a night to remember.
Townshend and Vedder will be accompanied by Zak Starkey (drums),Simon Townshend (guitar),Pino Palladino (bass),John Corey (keyboards),Loren Gold (keyboards) and Frank Simes (keyboards).
Tickets go on sale at 10 a.m. Tuesday, April 21, and reserved seats ($1,000, $750, $500, $250, $100) can be purchased at the Rosemont Theatre box office, online at Ticketmaster.com or by phone at 800-745-3000.
For more information, call the Rosemont Theatre at 847-671-5100.
Every hour, one young American is diagnosed with cancer. Teen Cancer America partners with hospitals throughout the United States to provide youth-oriented centers for teenagers and young adults. These units provide peer support and interaction while patients receive treatment at in-patient and out-patient clinics.
For more information, visit www.teencanceramerica.org.
Comments Disclaimer And Information